Published in Vopr Onkol on January 01, 1981
Toxic and gonadotropic effects of cadmium and boron relative to standards for these substances in drinking water. Environ Health Perspect (1976) 0.86
[Mistletoe lectins--antitumor effect and mechanism of action]. Vopr Onkol (2011) 0.84
[The characteristics of the biological action of low doses of irradiation]. Radiats Biol Radioecol (1996) 0.81
[Comparison of various physico-chemical properties of pig and cattle myeloperoxidases]. Biokhimiia (1982) 0.78
[Data on establishing a permissible level of boron content in drinking water]. Gig Sanit (1976) 0.76
Sensitivity of clonogenic cells of human ovarian ascitic cancer to antitumor drugs. Arch Geschwulstforsch (1988) 0.76
[Antitumor effect of joint action of low intensity electromagnetic fields and ultra low doses of doxorubicin]. Radiats Biol Radioecol (2003) 0.76
[Pathomorphological evaluation of combined antitumor therapy using cytostatics and immunomodulators in mouse lympholeukemia]. Biull Eksp Biol Med (1991) 0.75
[Effectiveness of Leukostim, a Russian preparation of granulocyte colony-stimulating factor, in the treatment of chemotherapy-induced neutropenia in patients with malignant tumors]. Vopr Onkol (2008) 0.75
[Determination of the kinetic parameters of tumor growth and an evaluation of the antitumor activity of chemotherapeutic preparations based on life expectancy]. Izv Akad Nauk SSSR Biol (1982) 0.75
[On kinetic criteria in oncology (reply to the critique of A. B. Faĭnshmidt)]. Vopr Onkol (1969) 0.75
[Breast cancer with low levels of blood lipids]. Vopr Onkol (1997) 0.75
[Effect of diazan on proliferation of human tumor cells]. Izv Akad Nauk SSSR Biol (1981) 0.75
[Analysis of the doubling time of various malignant neoplasms]. Izv Akad Nauk SSSR Biol (1971) 0.75
[Cytotoxic action of thiophosphamide on human tumor cells]. Farmakol Toksikol (1985) 0.75
[Treatment of erosive-ulcerous disorders of the upper gastrointestinal tract with dibunol]. Sov Med (1986) 0.75
[The EPR spectra of the ribonucleotide reductase in the tumorous tissues and organs of tumor-bearing animals]. Izv Akad Nauk SSSR Biol (1991) 0.75
[Potentials and prospects of human tumor cloning methods]. Med Radiol (Mosk) (1981) 0.75
[The pharmacokinetics of the antitumor preparation of dimetinur]. Eksp Onkol (1989) 0.75
[Analysis of the prognostic factors in stomach cancer]. Arkh Patol (1974) 0.75
[Survival kinetics of breast cancer patients undergoing combined chemotherapy for recurrences and metastases]. Vopr Onkol (1982) 0.75
[An autoradiographic study of adenocarcinoma of the stomach]. Vopr Onkol (1975) 0.75
[EPR study of the denitrosation of alkylnitrosoureas in vivo]. Izv Akad Nauk SSSR Biol (1986) 0.75
[Effect of chemotherapy on the survival of patients with disseminated melanoma of the skin]. Sov Med (1987) 0.75
[Changes in the proliferative activity of human breast cancer cells cultivated in vivo in diffusion chambers in response to antineoplastic agents]. Biull Eksp Biol Med (1981) 0.75
[Late results of gastric resection according to Billroth I in patients with cancer of the stomach]. Sov Med (1977) 0.75
[Chemotherapy of gastric cancer]. Vopr Onkol (1972) 0.75
[Alternative means of drug therapy in cancer: letril]. Vopr Onkol (2012) 0.75
[Taxotere and methylnitrosourea: experimental appraisal of combination chemotherapy]. Vopr Onkol (1999) 0.75
[Effect of dibunol liniment on posttraumatic skin regeneration in mice]. Biull Eksp Biol Med (1984) 0.75
[Optimization and prognosis of the effectiveness of using nitrosomethylurea for treating malignant tumor patients based on pharmacokinetic parameters]. Izv Akad Nauk SSSR Biol (1985) 0.75
[Kinetic regularities of survival of patients with inoperable gastric cancer]. Izv Akad Nauk SSSR Biol (1975) 0.75
[Ribonucleotide reductase--a "target" of the action of nitrosomethylurea]. Izv Akad Nauk SSSR Biol (1992) 0.75
[Time of doubling of the volume of malignant tumors as a criterion of the effectiveness of their treament]. Vopr Onkol (1979) 0.75
[A case of the successful use of nitrosomethylurea in lymphosarcoma complicated by prolonged massive chylothorax]. Vopr Onkol (1992) 0.75
[Polyacrylates of noble metals as potential antitumor drugs]. Biofizika (2015) 0.75
[Antiangiogenic and antitumor properties of cartilage]. Vopr Onkol (2012) 0.75
[Comparative evaluation of 2 schedules of administration of anti- neoplastic drugs by the CMF protocol in disseminated breast cancer]. Sov Med (1991) 0.75
[Cultivation of human gastric cancer tissue in diffusion chamber]. Vopr Onkol (1977) 0.75
[Characteristics of the growth rate of small-cell lung cancer]. Vopr Onkol (1989) 0.75
[Survival rate kinetics in patients with malignant tumors and the quantitative criteria of treatment effectiveness]. Med Radiol (Mosk) (1979) 0.75
[Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases]. Vopr Onkol (1980) 0.75
[Kinetics of changing unsaturation of blood lipids in mice with Lewis carcinoma]. Biull Eksp Biol Med (1994) 0.75
[The sensitivity of tumor cells to low doses of antitumor preparations]. Izv Akad Nauk Ser Biol (1995) 0.75
[Respiratory arrest following 5-fluorouracil administration]. Vopr Onkol (1992) 0.75
The study of the cytotoxic effect of anticancer drugs on human lung tumors transplanted to mice by use of diffusion chambers. Neoplasma (1985) 0.75
[Comparative evaluation of the antitumor, cytogenetic and immunodepressive effects of dimetinur when used perorally and parenterally]. Eksp Onkol (1988) 0.75
[The effect of chemotherapy on the total unsaturation and composition of plasma phospholipids and erythrocytes in patients with disseminated breast cancer]. Izv Akad Nauk SSSR Biol (1992) 0.75
[Sensitivity of clonogenic cells of human ascitic ovarian cancer to antitumor agents]. Eksp Onkol (1987) 0.75
[Cellular proliferative activity of human breast cancer]. Izv Akad Nauk SSSR Biol (1989) 0.75
[Survival of patients with disseminated small-cell lung cancer]. Vopr Onkol (1989) 0.75
[Comparative study of the cytotoxic effects of anthracycline antibiotics on heterotransplants of human breast cancer cultivated in diffusion chambers in vivo]. Antibiot Khimioter (1989) 0.75
[Alternative means of drug therapy of cancer: PC-SPES -- anticancer properties and mechanisms of action]. Vopr Onkol (2013) 0.75
[Evaluation of regimens for the simultaneous and sequential administration of cytostatics in the combined chemotherapy of disseminated forms of breast cancer]. Vopr Onkol (1985) 0.75
[Nitrosomethylurea in polychemotherapy of malignant tumors]. Sov Med (1977) 0.75
[The cytogenetic effect of ultralow doses of nitrosomethylurea]. Izv Akad Nauk Ser Biol (1996) 0.75
[Clonogenic cells in human tumors and the sensitivity to chemotherapy]. Eksp Onkol (1986) 0.75
[Relation of kinetic regularities of tumor growth to the survival of patients with malignant neoplasms]. Izv Akad Nauk SSSR Biol (1971) 0.75
[Nitrosomethylurea -- 30 years of study and use in the treatment of cancer patients]. Vopr Onkol (2001) 0.75
[The kinetics of the survival rate of patients following radical surgery for stomach cancer]. Vopr Onkol (1970) 0.75
The effect of diazane on the proliferation of human tumor cells. Biol Bull Acad Sci USSR (1982) 0.75
[14Co-dimetinur distribution in mice in relation to the stage of the development of tumor process]. Eksp Onkol (1990) 0.75
[Alternative means of drug therapy for cancer: antineoplastons--antitumor properties and mechanisms of action]. Vopr Onkol (2014) 0.75
[Green tea, a promising source of novel antitumor drugs?]. Vopr Onkol (2010) 0.75
[The sensitivity of experimental tumor systems to ultra low doses of doxorubicin]. Radiats Biol Radioecol (2003) 0.75
Kinetics of survival of patients with inoperable lung cancer and assessment of the efficacy of treatment. Biol Bull Acad Sci USSR (1980) 0.75
[Kinetic patterns of human tumor growth and the kinetic criteria for the effectiveness of its treatment]. Izv Akad Nauk SSSR Biol (1976) 0.75
[Cytotoxic action of doxorubicin and daunomycin on human lung cancer cells]. Antibiot Med Biotekhnol (1986) 0.75
[Chemotherapy effectiveness in lung cancer]. Sov Med (1980) 0.75
[Kinetic method of studying the survival of breast cancer patients following radical treatment]. Izv Akad Nauk SSSR Biol (1974) 0.75
[Survival kinetics of patients with inoperable lung cancer and evaluation of the effectiveness of treatment]. Izv Akad Nauk SSSR Biol (1980) 0.75
[The level of double bonds in the blood lipids of lung cancer patients]. Izv Akad Nauk Ser Biol (1993) 0.75
[The relationship between the doubling time of human lung tumor volume and the labelling index]. Biull Eksp Biol Med (1976) 0.75
[A clinico-statistical analysis of operable and inoperable stomach cancer patients]. Vopr Onkol (1972) 0.75
[Growth kinetics of nonexponentially growing tumors and the life expectancy of tumor carriers]. Izv Akad Nauk SSSR Biol (1987) 0.75
[Ultrasonic hemolysis of normal and pathological erythrocytes]. Biofizika (1982) 0.75
[Breast cancer therapy with combination of endocrine and target drugs]. Vopr Onkol (2011) 0.75
[Comparison of blood-serum p53 concentrations in patients with advanced breast tumors before and after chemotherapy]. Vopr Onkol (2006) 0.75
The effect of thiophosphamide on the proliferative activity of human tumor cells cultured in vivo in diffusion chambers. Arch Geschwulstforsch (1984) 0.75
[Antiulcer activity of dibunol in experimental stomach and duodenal ulcers]. Farmakol Toksikol (1988) 0.75
[Kinetic patterns in the survival of breast cancer patients with recurrence and metastases]. Vopr Onkol (1978) 0.75
[Comparative evaluation of the effectiveness of antitumor preparations in human lung cancer xenografts growing on mice in diffusion chambers]. Izv Akad Nauk SSSR Biol (1985) 0.75
[Autoradiographic study of human scirrhous gastric carcinoma during cultivation in diffusion chambers]. Biull Eksp Biol Med (1975) 0.75
[Effect of anthracycline antibiotics on the cellular proliferation of human breast cancer heterografts growing in diffusion chambers in vivo]. Izv Akad Nauk SSSR Biol (1989) 0.75
[Cellular proliferative activity of human lung tumors]. Izv Akad Nauk SSSR Biol (1984) 0.75
Inhibition of tumor growth with ultralow doses of doxorubicin under experimental conditions. Bull Exp Biol Med (2003) 0.75
[Effect of antitumor preparations on the cellular proliferation of human gastrointestinal tract tumors cultured in diffusion chambers in vivo]. Izv Akad Nauk SSSR Biol (1983) 0.75
[Unsaturated blood lipids in breast cancer patients]. Izv Akad Nauk Ser Biol (1995) 0.75
[Pharmacokinetics of nitrosomethylurea in oncologic patients]. Vopr Onkol (1988) 0.75
[The cellular proliferation of breast cancer]. Vopr Onkol (1990) 0.75
[Survival of 5-fluorouracil-treated stomach cancer patients in the far-advanced stages]. Vopr Onkol (1978) 0.75
[Evaluation of the effectiveness of cancer chemotherapy from survival data]. Izv Akad Nauk SSSR Biol (1972) 0.75
[Survival of patients with inoperable stomach cancer treated with 5-fluorouracil]. Vopr Onkol (1976) 0.75
[Assessment of the prognostic value of clinico-morphologic factors in breast cancer using a computer]. Vopr Onkol (1981) 0.75
[Autoradiographic study of the gastric mucosa in cancer]. Vopr Onkol (1976) 0.75
[Enhanced proliferation of human lung cancer cells during culture in diffusion chambers]. Vopr Onkol (1984) 0.75
[The use of gemcitabine in the treatment of patients with mesothelioma]. Vopr Onkol (2006) 0.75
[Patient survival rate in inoperable stomach cancer]. Vopr Onkol (1980) 0.75
[Level of double bonds in lipids in human plasma and erythrocytes]. Patol Fiziol Eksp Ter (1996) 0.75
[Labelling index and prognosis in stomach cancer patients]. Izv Akad Nauk SSSR Biol (1977) 0.75